Drug

Kojic Acidskin Lightening

75 flagged reaction(s) · 1,481 total co-reports · max PRR 35.6

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Hepatic Function Abnormal	106	35.6	37.9	signal
2	Lymphocyte Count Decreased	50	35.2	36.2	signal
3	Neutrophil Count Increased	28	33.9	34.4	signal
4	Drug-induced Liver Injury	69	27.8	28.9	signal
5	Sputum Discoloured	16	21.0	21.2	signal
6	Hypocalcaemia	30	19.7	20.1	signal
7	Obstructive Airways Disorder	17	18.9	19.1	signal
8	Full Blood Count Abnormal	16	18.8	19.0	signal
9	Myelosuppression	50	18.2	18.8	signal
10	Liver Injury	35	18.0	18.3	signal
11	Neutrophil Count Decreased	55	16.9	17.4	signal
12	Blood Lactate Dehydrogenase Increased	21	16.3	16.5	signal
13	Blood Urea Increased	22	16.2	16.4	signal
14	Alanine Aminotransferase Increased	72	14.5	15.2	signal
15	Tendonitis	18	14.4	14.5	signal
16	Aspartate Aminotransferase Increased	61	14.3	14.8	signal
17	Gamma-glutamyltransferase Increased	24	13.4	13.6	signal
18	Pulmonary Mass	16	13.4	13.5	signal
19	Blood Bilirubin Increased	28	12.8	13.0	signal
20	Sleep Disorder Due To A General Medical Condition	16	12.3	12.4	signal
21	Lung Infection	15	11.8	11.9	signal
22	Transaminases Increased	21	11.7	11.9	signal
23	Hypomagnesaemia	13	11.6	11.7	signal
24	Hypokalaemia	43	11.6	11.9	signal
25	Platelet Count Decreased	96	11.2	11.8	signal
26	Bone Marrow Failure	18	10.9	11.0	signal
27	Electrolyte Imbalance	10	10.8	10.8	signal
28	Hepatic Failure	24	9.9	10.0	signal
29	White Blood Cell Count Increased	30	9.7	9.8	signal
30	White Blood Cell Count Decreased	79	9.0	9.4	signal
31	Muscle Atrophy	9	8.9	8.9	signal
32	C-reactive Protein Increased	26	8.9	9.0	signal
33	Coagulopathy	11	8.2	8.3	signal
34	Hepatic Encephalopathy	6	8.0	8.0	signal
35	Seasonal Allergy	9	7.9	7.9	signal
36	Autoimmune Disorder	6	7.8	7.8	signal
37	Upper Gastrointestinal Haemorrhage	10	7.4	7.4	signal
38	Cholecystitis	7	7.3	7.3	signal
39	Hyperbilirubinaemia	6	7.2	7.2	signal
40	Disseminated Intravascular Coagulation	8	7.0	7.1	signal
41	Lymphadenopathy	20	7.0	7.1	signal
42	Blood Triglycerides Increased	10	7.0	7.0	signal
43	Stomatitis	33	6.7	6.9	signal
44	Hepatotoxicity	12	6.7	6.8	signal
45	Ligament Sprain	5	6.3	6.3	signal
46	Salivary Hypersecretion	5	6.2	6.2	signal
47	Platelet Count Increased	6	5.7	5.7	signal
48	Oral Pain	10	5.5	5.5	signal
49	Metastases To Lung	5	5.4	5.4	signal
50	Wrist Fracture	5	5.2	5.2	signal
51	Jaundice	11	5.1	5.1	signal
52	Pneumonitis	11	5.0	5.1	signal
53	Dermatitis Allergic	5	5.0	5.0	signal
54	Leukopenia	20	5.0	5.0	signal
55	Thyroid Disorder	6	4.8	4.8	signal
56	Mucosal Inflammation	10	4.8	4.8	signal
57	Agranulocytosis	7	4.7	4.7	signal
58	Eczema	19	4.7	4.7	signal
59	Acute Hepatic Failure	5	4.6	4.6	signal
60	Myocarditis	4	4.4	4.4	signal
61	Hepatocellular Injury	5	4.4	4.4	signal
62	Peritonitis	7	4.2	4.2	signal
63	Rhabdomyolysis	14	4.2	4.2	signal
64	Tendon Rupture	4	4.0	4.0	signal
65	Premature Delivery	5	3.9	3.9	signal
66	Decreased Immune Responsiveness	3	3.8	3.8	no signal
67	Metastases To Bone	5	3.8	3.8	signal
68	Ovarian Cyst	3	3.7	3.7	no signal
69	Injection Site Discomfort	3	3.6	3.6	no signal
70	Acute Myeloid Leukaemia	4	3.2	3.2	signal
71	Abnormal Weight Gain	3	3.0	3.0	no signal
72	Hair Colour Changes	3	3.0	3.0	no signal
73	Injection Site Induration	3	2.9	2.9	no signal
74	Plasma Cell Myeloma	8	2.5	2.5	signal
75	Dermatitis Atopic	5	1.2	1.2	no signal